Dimensional Fund Advisors
AKCA

Dimensional Fund Advisors’s Akcea Therapeutics Inc AKCA Stock Holding History

Dimensional Fund Advisors’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,950
Closed -$362K – 3396
2020
Q3 		$362K Hold
19,950
– – ﹤0.01% 3123
2020
Q2 		$273K Buy
19,950
+3,691
+23% +$57K ﹤0.01% 3180
2020
Q1 		$233K Sell
16,259
-3,623
-18% -$59.5K ﹤0.01% 3185
2019
Q4 		$337K Buy
19,882
+4,916
+33% +$91.5K ﹤0.01% 3192
2019
Q3 		$230K Buy
+14,966
New +$319K ﹤0.01% 3260

Dimensional Fund Advisors's AKCA Position: Q4 2020 in Review

Dimensional Fund Advisors sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 19,950 shares — an estimated $362K sold.

Dimensional Fund Advisors first reported a position in AKCA in Q3 2019 and held it in 5 quarters. The position peaked at $362K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Dimensional Fund Advisors reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 19,950 Akcea Therapeutics Inc shares in Q4 2020, an estimated $362K.
  • Dimensional Fund Advisors first reported a position in Akcea Therapeutics Inc in Q3 2019 and held it in 5 quarters.
  • Dimensional Fund Advisors's Akcea Therapeutics Inc position peaked at $362K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Dimensional Fund Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.